Peripheral Nervous System Diseases Withdrawn Phase 2 Trials for Sulfate ion (DB14546)
Also known as: Peripheral Nervous System Disorders / Peripheral Nervous System Disease / Neuropathy peripheral / Peripheral nerve disorder NOS / Peripheral neuropathy NOS / Peripheral neuropathy / Peripheral neuropathies / Disorder of peripheral nervous system NOS / Peripheral nerve disease (disorder) / Disorder of the peripheral nervous system (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029829 (Peripheral Nervous System Diseases) | Withdrawn | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03109301 | Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) | Treatment |